FDA Investigator Edward Deberry
Edward Deberry has inspections in 4 countries as of 24 Aug 2023. Edward Deberry has collaborated with a combinined 3400 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
308
Last Inspection Date:
24 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Hungary,
Italy,
Switzerland
Co-Investigator(s):
Aaron P Wozniak,
Abdur Rashid,
Adam R Cooke,
Alaric C Denton,
Allen F Hall,
Alphonso A Haupt, III,
Amanda L Evanco,
Amy A Johnson,
Amy H Ruble,
Ana L Kewes,
Anastasia M Shields,
Ann B Borromeo,
April R Bowen,
Arlyss M Jones,
Arthur G Hurst,
Babatunde D Babalola,
Betsy C Galliher,
Billy M Battles,
Bonita S Chester,
Brandy D Brown,
Brenda Rivera,
Brentley S Collins,
Brian A Graves,
Bridegan,
Brown,
Buford,
Burnell M Henry,
Carl A Anderson,
Carol F Robinson,
CDR Thomas R Berry, PPh,
Chapman,
Cherrie A Zachary,
Cherry R Valerio,
Cheryl D Barton,
Chestnut,
Christopher B May,
Christopher J Adams,
Christopher S Keating,
Claudette D Brooks,
Constance Y Fears,
Contractor Bridgers,
Cordelia J Brammer,
Crystal A Harlan,
Cynthia Jim, CSO,
D Ross Spears, PhD,
Daphne Santiago, PhD,
Darla J Christopher,
David J Leray,
David T Glover,
David Williams,
Davis,
Deborah A Greco,
Debra J Tucker,
Dellarese L Herbert,
Derek C Price,
Devaughn Edwards,
Dorothy P Kramer,
Douglas L Page,
Edecia A Richards,
Eileen J Bannerman,
Eliezar Ramos,
Eric S Weilage,
Erika M Wilkerson,
Ernest H Blackwood,
Esra Toussaint,
Fabian Nchaparro Rodriguez,
Gabriel R Mclemore,
Gamal A Norton,
Gary E Coleman, Jr, REHS,
Gates E Raynor,
Gideon N Esuzor,
Gray,
Hai Lien T Phung,
Helen R Bester,
Hristu B Chepa,
Hudson,
Ibad U Khan,
Igbinoba,
Ivery,
Ivy E Sweeney,
Jacqueline Mdiaz Albertini,
James P Lewis, Jr,
Janet B Gray,
Jared P Stevens,
Jason F Chancey,
Jason K Morgan,
Jawaid Hamid,
Jeffrey D Sheppard,
Jennifer L Bridgewater,
Jimmy O Buford,
John D Lloyd,
John E Aghadia,
Johnson,
Joseph F Owens,
Julie D Bringger,
Justin A Boyd,
Kemejumaka N Opara,
Kenny R Robinson,
Kewes,
Kimberly Cdelk Brooks,
Kip J Hanks,
Kunapuli T Madhusudhan,
Lareese K Thomas,
Larry K Hampton,
Laurice Mccoy,
Lawrence,
Lawrence S Newsom,
Lesley K Satterwhite,
Leslie W Gilbert,
Libia M Lugo,
Lillie D Witcher,
Mancia R Walker,
Marc A Alston,
Marcella D Crook,
Margaret Torres Vazquez,
Marie F Morin,
Mark C Saale,
Marla A Cassidy,
Mary Alice Papdimitriou,
Mary F Bodick,
Marybeth Willis,
Matthew G Brown,
Maya M Davis,
Mcbean,
Melanie M Walker,
Metitia G Sanders,
Metitia M Gramby,
Miaja Umaedi,
Michelle D Haamid,
Michelle L Jones,
Mihaly S Ligmond,
Mokhless A Ghaly,
Morrell,
Nancy E Fontaine,
Nicholas M Smith,
Nicole A Lloyd,
Nicole D Lyons,
Pamela L Vega,
Panney H Mccarver,
Paul A Bonneau,
Paula J Bretz,
Penny H Mccarver,
Perry H Gambrell,
Prabhu P Raju,
R Edwadebey Deberry,
Rachael L Cook,
Radona R Boutte,
Randy L Clarida,
Rashard A Knight,
Rashonda N Rucker,
Rebecca Rodriguez,
Richard J Bashay,
Richard L Garcia,
Robert C Coleman,
Robert D Tollefsen,
Robert J Rutherford,
Robert Q Green,
Robert W Turner,
Robin N Goins,
Russell K Riley,
Sally Gopaul,
Sandra I Gaul,
Sandra R Saunders,
Scott T Ballard,
Seneca D Toms,
Sereen Gmorgan Murray,
Shayla G Turnipseed,
Shusheen A Alexander,
Simone M Edmonson,
Siobhan G Taylor,
Smith,
Sonya M Edmonds,
Stanley Nelson,
State Agency,
Stephanie E Hubbard,
Stephanie L Kelly,
Stephen D Brown,
Steven M Weinman,
Susan M Taylor,
Tallman,
Tamara M Casselman,
Tammara A Newberry,
Tammara A Stephens,
Theresa L Stewart,
Timothy T Kapsala,
Tomika L Bivens,
Tracy K Bell,
Tracy L Ramseur,
Tracy R Ball,
Tyrico K English,
Vanessa E Coulter,
Veronica Fuentes, MS,
Vicky C Stoakes,
Victoria L Palmer,
Vincent M Williams,
Viviana Matta,
Walker,
Washington,
Watson,
Weedb,
William P Tonkins,
Williams,
Young Kim
Edward Deberry's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2009 | EIR | Nypro Inc. - EIR, 2009-09-09 |
June, 2010 | EIR | Greer Laboratories, Inc. - EIR, 2010-06-29 |
September, 2015 | FDA 483 | King Bio Inc. - Form 483, 2015-09-04 |
September, 2008 | EIR | Greer Laboratories, Inc. - EIR, 2008-09-15 |
September, 2007 | EIR | Baxter Healthcare Corporation - EIR, 2007-09-19 |
September, 2006 | EIR | Greer Laboratories, Inc. - EIR, 2006-09-18 |
September, 2012 | EIR | Nypro Inc. - EIR, 2012-09-12 |
September, 2008 | FDA 483 | King Bio Inc. - Form 483, 2008-09-25 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more